| Structure | Chemical Name | CAS | MF |
|
N,2,4,5-Tetra(2-hydroxypropyl)-m-xylene-α,α'-diamine
|
|
|
|
N-[[1,2,3,4-Tetrahydro-7-propyloxynaphthalen]-1-yl]adenosine
|
|
C23H29N5O5
|
|
N-((Tetrahydrothiophen)-3-yl)amidosulfuric acid sodium salt
|
|
C6H7NNaO3S5
|
|
N-(1,2,5,6-Tetrahydro-2,6-dioxo-5-ethyl-5-phenylpyridin-3-yl)acetamide
|
14387-64-5
|
C15H16N2O3
|
|
[N-(2-Tetradecanoylaminoethyl)-N-(2-hydroxyethyl)amino]acetic acid 2-hydroxypropyl ester
|
|
C23H46N2O5
|
|
N6-(8-Tetradecenoyl)-N2,N2-dimethyllysine
|
|
C22H42N2O3
|
|
N6-(2-Tetradecenoyl)lysine
|
|
C20H38N2O3
|
|
|
N-(1,2,2,2-Tetrachloroethylthio)-4-cyclohexene-1,2-dicarbimide
|
|
|
|
N6-(11-Tetradecenoyl)lysine
|
|
C20H38N2O3
|
|
N-[(Tetrahydrothiophene 1,1-dioxide)-3-yl]methionine sodium salt
|
|
C9H16NNaO4S2
|
|
4-[N-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethylnaphthalen)-2-yl]methylaminocarbonyl]benzoic acid
|
|
C23H27NO3
|
|
N-[2-[1-[4-(1,1,3,3-Tetramethylbutyl)phenoxy]ethoxy]ethyl]-N,N-dimethyl-N-benzylaminium
|
|
C27H42NO2+
|
|
N-[[1,2,3,4-Tetrahydro-6-methoxynaphthalen]-1-yl]adenosine
|
|
C21H25N5O5
|
|
N-[[(2,3,4,5-Tetrahydro-1-hydroxy-1H-benzocyclohepten)-1-yl]methyl]adenosine
|
|
C22H27N5O5
|
|
N6-(4-Tetradecenoyl)-N2,N2-dimethyllysine
|
|
C22H42N2O3
|
|
N-(2,3,5,6-Tetrafluorophenyl)maleimide
|
|
C10H3F4NO2
|
|
N6-(12-Tetradecenoyl)lysine
|
|
C20H38N2O3
|
|
N-[2,3,6,7-Tetrahydro-1H,5H-benzo[ij]quinolizin-9-yl]formamide
|
|
C13H16N2O
|
|
N-[3-(2,3,4,9-TETRAHYDRO-1H-B-CARBOLIN-1-YL)-PROPYL]-GUANIDINE
|
82264-57-1
|
C15H21N5
|
|
|
N-(1-Tetracosenylsulfonyl)-β-alanine potassium salt
|
|
|
|
N-[[1,2,3,4-Tetrahydro-5-ethoxynaphthalen]-1-yl]adenosine
|
|
C22H27N5O5
|
|
|
N,2,3,5-Tetra(2-hydroxypropyl)-p-xylene-α,α'-diamine
|
|
|
|
N-[[1,2,3,4-Tetrahydronaphthalen]-1-yl]adenosine
|
|
C20H23N5O4
|
|
|
N-{4-(1,1,3,3-Tetramethylbutyl)phenoxyethoxyethyl}-N,N-dimethyl-N-benzylammonium salt
|
|
|
|
3-(N-Tetradecanoyl-N-methylamino)-1-propanesulfonic acid potassium salt
|
|
C18H36KNO4S
|
|
N-[2-[(Tetrahydro-2,4-dioxo-5-hydroxy-1H-imidazol)-5-yl]phenyl]carbamic acid benzyl ester
|
|
C17H15N3O5
|
|
N-[1-(Tetradecylamino)propyl]aminoacetic acid
|
|
C19H40N2O2
|
|
N2-(4-Tetradecenoyl)-N1,N5-dibutylglutaminamide
|
|
C27H51N3O3
|
|
N-(1,1,3,3-Tetramethylbutyl)-2-hydroxypropionamide
|
64058-35-1
|
|
|
N-[(1,3,4,7-Tetrahydro-2,4,7-trioxo-2H-pyrano[2,3-d]pyrimidin)-6-yl]benzamide
|
|
C14H9N3O5
|
|
N-Tetradecylpiperidine-1-ethanamine
|
|
C21H44N2
|
|
N-Tetradecylsulfonylglycine sodium salt
|
|
C16H32NNaO4S
|
|
N-[[(1,2,3,4-Tetrahydro-1-hydroxynaphthalen)-1-yl]methyl]adenosine
|
|
C21H25N5O5
|
|
N6-(13-Tetradecenoyl)lysine
|
|
C20H38N2O3
|
|
|
N,3,5,6-Tetra(2-hydroxypropyl)-o-xylene-α,α'-diamine
|
|
|
|
N6-(8-Tetradecenoyl)lysine
|
|
C20H38N2O3
|
|
|
N,3,4,6-Tetra(2-hydroxypropyl)-o-xylene-α,α'-diamine
|
|
|
|
N6-(3-Tetradecenoyl)lysine
|
|
C20H38N2O3
|
|
|
N-[(1,2,3,6-Tetrahydro-1-methyl-2,6-dioxopyrimidin)-4-ylcarbonyl]-L-His-L-Pro-NH2
|
|
|
|
N6-(6-Tetradecenoyl)-N2,N2-dimethyllysine
|
|
C22H42N2O3
|
|
N-[(1,2,3,4-Tetrahydroacridin)-9-yl]-1,4-dihydro-1-propylpyridine-3-carboxamide
|
|
C22H25N3O
|
|
N2-(8-Tetradecenoyl)-N1,N5-dibutylglutaminamide
|
|
C27H51N3O3
|
|
N-[1-[2-(Tetradecylamino)ethylamino]ethyl]glycine
|
|
C20H43N3O2
|
|
N-(1,2,3,4-Tetrahydroquinoline-6-yl)acetamide
|
|
C11H14N2O
|
|
N2-(6-Tetradecenoyl)-N1,N5-dibutylglutaminamide
|
|
C27H51N3O3
|
|
|
N,4,5,6-Tetra(2-hydroxypropyl)-o-xylene-α,α'-diamine
|
|
|
|
N-[1-[1-[4-(1,1,3,3-Tetramethylbutyl)phenoxy]ethoxy]ethyl]-N,N-dimethyl-N-benzylaminium
|
|
C27H42NO2+
|
|
N-[(5,13,17,18-Tetrahydro-5,13,18-trioxoanthra[1,9-ab]naphtho[2,3-i]carbazol)-6-yl]benzamide
|
70788-48-6
|
C38H20N2O4
|
|
N6-(11-Tetradecenoyl)-N2,N2-dimethyllysine
|
|
C22H42N2O3
|
|
4-[N-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethylnaphthalen)-2-yl]carbonyl]methylamino]benzoic acid
|
|
C23H27NO3
|
|
N-[2-[3-[(Tetrahydro-2H-pyran)-2-yloxy]-1-propynyl]phenyl]acetamide
|
|
C16H19NO3
|
|
N,4,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine
|
35973-44-5
|
|
|
N-[(1,2,3,4-Tetrahydroacridin)-9-yl]-6-hydroxy-1-methyl-1,4,5,6-tetrahydropyridine-3-carboxamide
|
|
C20H23N3O2
|
|
4-[N-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethylnaphthalen)-2-ylcarbonyl]methylamino]benzoic acid methyl ester
|
|
C24H29NO3
|
|
N-[[1,2,3,4-Tetrahydro-7-benzyloxynaphthalen]-1-yl]adenosine
|
|
C27H29N5O5
|
|
2-[[N-[[(Tetrahydro-4-hexadecyloxymethylfuran)-2-yl]methoxycarbonyl]amino]methyl]-1-ethylpyridinium
|
|
C31H55N2O4+
|
|
N-[(1,2,3,4-Tetrahydroisoquinolin)-5-yl]-3,4,5-trimethoxybenzamide
|
|
C19H22N2O4
|
|
N-[2-(Tetradecylamino)propyl]aminoacetic acid
|
|
C19H40N2O2
|
|
N-[2-[1-(Tetradecylamino)ethylamino]ethyl]glycine
|
|
C20H43N3O2
|
|
N-Tetracosylsulfonylglycine sodium salt
|
|
C26H52NNaO4S
|
|
N-(2,3,6,7-Tetrahydro-1H,5H-benzo[ij]quinolizin-9-yl)carbamic acid methyl ester
|
|
C14H18N2O2
|
|
N-[1,2,3,4-Tetrahydro-6-methyl-3-(phenylacetylamino)-4-(p-toluidino)quinolin-2-ylmethyl]phenylacetamide
|
|
C34H36N4O2
|
|
N6-(10-Tetradecenoyl)lysine
|
|
C20H38N2O3
|
|
N-[[1,2,3,4-Tetrahydro-5-isopropyloxynaphthalen]-1-yl]adenosine
|
|
C23H29N5O5
|
|
N-[(1,2,3,4-Tetrahydro-1-hydroxy-5,8-dimethoxynaphthalen)-1-ylmethyl]-2,2,2-trifluoroacetamide
|
|
C15H18F3NO4
|
|
N-[2-(Tetradecyloxy)-2-oxoethyl]trimethylaminium
|
|
C19H40NO2+
|
|
N-Tetradecanoyltaurine sodium salt
|
|
C16H32NNaO4S
|
|
N-[(1,2,5,6-Tetrahydropyridin)-1-yl]pyridine-3-carboxamide
|
|
C11H13N3O
|
|
N-[2,9,10,14-Tetrakis[(trimethylsilyl)oxy]-1-[[(trimethylsilyl)oxy]methyl]-3-heptadecenyl]acetamide
|
56247-92-8
|
C35H79NO6Si5
|
|
|
Nsp100 kinase
|
|
|
|
|
NtGA protein
|
|
|
|
|
(-)-N-[(S)-p-Methoxy-α-methylbenzyl]dibenzoylamine
|
|
|
|
N-[(2R,3Z)-4-Methyl-5-hydroxy-3-penten-2-yl]adenosine
|
|
C16H23N5O5
|
|
|
(-)-N-[(S)-p-Methoxy-α-(quinoxaline-2-yl)phenethyl]phthalimide
|
|
|
|
|
(-)-N-[(S)-p-Methoxy-α-methylbenzyl]phthalimide
|
|
|
|
|
NSPL1 protein
|
|
|
|
|
N-(Texas Red sulfonyl)-5-dodecanoylamine
|
|
|
|
|
N-(Texas Red sulfonyl)-6-dodecanoylamine
|
|
|
|
|
N-(TEXAS RED(R) SULFONYL)-1,2-DIHEXADECANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, TRIETHYLAMMONIUM SALT
|
|
|
|
|
N-(TEXAS RED(R)-X)-1,2-DIHEXADECANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, TRIETHYLAMMONIUM SALT
|
|
|
|
|
N-SOYA-1,3-DIAMINOPROPANE
|
|
|
|
|
N-(Soybean oil alkyl)-N-ethyl-morpholinium ethosulfate
|
|
|
|
N-[(1S)-3-Oxo-1-phenylpropyl]-carbaMic Acid PhenylMethyl Ester
|
376348-79-7
|
C17H17NO3
|
|
|
NSP3 (Novel SH2-containing Protein 3), SH2D3C (SH2 domain-containing 3C), ~50kD, Goat anti-Human, WB
|
|
|
|
|
N-[[(S)-2-Oxopiperidin-6-yl]carbonyl]-L-Nva-L-Pro-NH2
|
|
|
|
|
N-[[[1S,(+)]-3-Oxo-2α-[(Z)-2-pentenyl]cyclopentane-1β-yl]acetyl]-D-valine
|
|
|
|
|
N-[[(S)-2-Oxopyrrolidin-5-yl]carbonyl]-L-Nva-L-Pro-NH2
|
|
|
|
|
N-[[[1S,(+)]-3-Oxo-2α-[(Z)-2-pentenyl]cyclopentane-1β-yl]acetyl]-L-glutamic acid
|
|
|
|
|
N-[[[1S,(+)]-3-Oxo-2α-[(Z)-2-pentenyl]cyclopentane-1β-yl]acetyl]-L-phenylalanine
|
|
|
|
|
N-[[(2S)-6-Oxopiperidin-2-yl]carbonyl]-L-Leu-Gly-NH2
|
|
|
|
|
N-[[[1S,(+)]-3-Oxo-2α-[(Z)-2-pentenyl]cyclopentane-1β-yl]acetyl]-L-leucine
|
|
|
|
|
N-[[[1S,(+)]-3-Oxo-2α-[(Z)-2-pentenyl]cyclopentane-1β-yl]acetyl]-D-phenylalanine
|
|
|
|
|
N-[[(2S)-Oxolan-2-yl]carbonyl]-L-Leu-Gly-NH2
|
|
|
|
|
N-[[(3S)-6-Oxo-3,6-dihydro-2H-pyran]-3β-yl]carbamic acid tert-butyl ester
|
|
|
|
|
N-[[(S)-2-Oxopiperidin-6-yl]carbonyl]-L-His-L-Pro-NH2
|
|
|
|
|
N-[[[1S,(+)]-3-Oxo-2α-[(Z)-2-pentenyl]cyclopentane-1β-yl]acetyl]-L-aspartic acid
|
|
|
|
|
N-[[[1S,(+)]-3-Oxo-2α-[(Z)-2-pentenyl]cyclopentane-1β-yl]acetyl]-L-valine
|
|
|
|
|
N-[[(2S)-5-Oxopyrrolidin-2-yl]carbonyl]-L-Leu-Gly-NH2
|
|
|
|
N-[3-[(4S)-5-Oxo-1-phenyl-2-thioxoimidazolidin-4-yl]propyl]urea
|
|
C13H16N4O2S
|
|
|
Nsp1p
|
|
|